Novartis AG (NYSE:NVS) Q1 2025 Earnings Conference Call April 29, 2025 8:00 AM ET
Company Participants
Sloan Simpson – Head of Investor Relations
Vas Narasimhan – CEO
Harry Kirsch – CFO
Conference Call Participants
Simon Baker – Redburn Atlantic
Graham Parry – Bank of America
Emmanuel Papadakis – Deutsche Bank
Florent Cespedes – Bernstein
Peter Verdult – BNP Paribas Exane
Richard Vosser – JPMorgan
James Quigley – Goldman Sachs
Thibault Boutherin – Morgan Stanley
Matthew Weston – UBS
Kerry Holford – Berenberg
Seamus Fernandez – Guggenheim
Steve Scala – TD Securities
Operator
Good morning and good afternoon, and welcome to the Novartis Q1 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. With that, I would like to hand over to Ms. Sloan Simpson, Head of Investor Relations. Please go ahead, madam.
Sloan Simpson
Thank you, Heidi. Good morning and good afternoon, everyone, and welcome to our Q1 2025 earnings call. The information presented today contains forward-looking statements that have involved known and unknown risks, uncertainties, and other factors. These may cause actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company’s Form 20-F and its most recent quarterly results on Form 6-K that respectively were filed with and furnished to the U.S. Securities and Exchange Commission. Before we get started, I just want to reiterate Heidi’s guidance for our analysts. Please limit yourselves to one question at a time, and we’ll cycle through the queue as many times as we can.
And with that, I will hand over to Vas.
Vas Narasimhan
Thank you, Sloan. And thanks
